Cas Medical Systems

BD acquired the Critical Care products group from Edwards Lifesciences in 2024 - now known as Advanced Patient Monitoring. Please visit our LinkedIn page: CASMED was acquired by Edwards Lifesciences under the Critical Care products group in CASMED designs and manufactures FORE-SIGHT tissue oximetry, which uses five wavelengths of light and a complex algorithm to generate readings you can trust. FORE-SIGHT alone offers a full family of sensors, providing three depths of light penetration. Users can specify an adult or pediatric patient, and can select from multiple sensor locations, fine-tuning the algorithm to the unique properties of specific tissue beds. FORE-SIGHT’s unparalleled accuracy gives you the confidence of knowing your patient’s brain is adequately oxygenated.